CFTR and cystic fibrosis: Recently, a new highly effective modulator therapy (HEMT) named Trikafta [11,12] has made a significant change in the lives of people with CF with at least one copy of F508del-CFTR, altogether representing ~80–85% of all individuals with CF [11,12].